This test provides the quantitative determination of total tau protein to support the diagnosis of Alzheimer’s disease.
This test provides the quantitative determination of tau protein phosphorylated at threonine 181 (pTau181), to support the diagnosis of Alzheimer’s disease.
Test for the determination of human autoantibodies against NMDAR to support the diagnosis of paraneoplastic neurological syndromes with an intermediate-risk phenotype.
This test detects human antibodies of the immunoglobulin class IgG against muscle-specific kinase (MuSK), to support the diagnosis of myasthenia gravis.
This test detects human antibodies of the immunoglobulin class IgG against antigens located in the cardiac and skeletal muscle, to support the diagnosis of myasthenia gravis.
This test detects human antibodies of the immunoglobulin class IgG against myelin oligodendrocyte glycoprotein (MOG), to support the diagnosis of demyelinating diseases of the central nerve system.
Test for the determination of human autoantibodies against LGI1 protein to support the diagnosis of paraneoplastic neurological syndromes with a low-risk phenotype.
Test for the determination of human autoantibodies against DPPX protein to support the diagnosis of paraneoplastic neurological syndromes with a low-risk phenotype.
Subscribe to our newsletter to be always updated.